IL22 and colitis: Administration of some strains of L.reuteri alone or in combination with other Lactobacillus strains has been reported to prevent DSS-induced colitis in mice due to various mechanisms (91–94) and some studies suggest that AHR activation and enhanced IL-22 production play a critical role in the process (91, 92).